ATE277605T1 - Alginsaure enthaltende enterischer ueberzug fuer eine orale zubereitung - Google Patents
Alginsaure enthaltende enterischer ueberzug fuer eine orale zubereitungInfo
- Publication number
- ATE277605T1 ATE277605T1 AT97924938T AT97924938T ATE277605T1 AT E277605 T1 ATE277605 T1 AT E277605T1 AT 97924938 T AT97924938 T AT 97924938T AT 97924938 T AT97924938 T AT 97924938T AT E277605 T1 ATE277605 T1 AT E277605T1
- Authority
- AT
- Austria
- Prior art keywords
- enteric coating
- coating containing
- oral preparation
- algin acid
- containing algin
- Prior art date
Links
- 235000010443 alginic acid Nutrition 0.000 title abstract 2
- 229920000615 alginic acid Polymers 0.000 title abstract 2
- 239000002702 enteric coating Substances 0.000 title abstract 2
- 238000009505 enteric coating Methods 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 235000013912 Ceratonia siliqua Nutrition 0.000 abstract 1
- 240000008886 Ceratonia siliqua Species 0.000 abstract 1
- 239000001828 Gelatine Substances 0.000 abstract 1
- 239000000783 alginic acid Substances 0.000 abstract 1
- 229960001126 alginic acid Drugs 0.000 abstract 1
- 150000004781 alginic acids Chemical class 0.000 abstract 1
- 235000021120 animal protein Nutrition 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 230000037406 food intake Effects 0.000 abstract 1
- 229920000159 gelatin Polymers 0.000 abstract 1
- 235000019322 gelatine Nutrition 0.000 abstract 1
- 239000000416 hydrocolloid Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000008188 pellet Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
- 235000013311 vegetables Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Jellies, Jams, And Syrups (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK63696 | 1996-06-06 | ||
| PCT/DK1997/000252 WO1997046224A1 (en) | 1996-06-06 | 1997-06-06 | Enteric coating, comprising alginic acid, for an oral preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE277605T1 true ATE277605T1 (de) | 2004-10-15 |
Family
ID=8095832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97924938T ATE277605T1 (de) | 1996-06-06 | 1997-06-06 | Alginsaure enthaltende enterischer ueberzug fuer eine orale zubereitung |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6455052B1 (de) |
| EP (1) | EP0952824B1 (de) |
| JP (1) | JP2000514406A (de) |
| KR (1) | KR20000016331A (de) |
| CN (1) | CN1147291C (de) |
| AT (1) | ATE277605T1 (de) |
| AU (1) | AU717817B2 (de) |
| BR (1) | BR9709535A (de) |
| CA (1) | CA2257378C (de) |
| DE (1) | DE69730991T2 (de) |
| IL (1) | IL127378A (de) |
| NO (1) | NO327294B1 (de) |
| NZ (1) | NZ333182A (de) |
| WO (1) | WO1997046224A1 (de) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3142820B2 (ja) * | 1998-08-27 | 2001-03-07 | 株式会社エヌ・ティ・ティ・ドコモ | プッシュ型情報配信方法およびその中継装置 |
| JP3142821B2 (ja) * | 1998-08-27 | 2001-03-07 | 株式会社エヌ・ティ・ティ・ドコモ | 情報通信ネットワークの課金方法 |
| KR100823908B1 (ko) * | 2000-10-20 | 2008-04-21 | 바이오비트럼 에이비(피유비엘) | 2-, 3-, 4-, 또는 5-치환-n1-(벤젠술포닐)인돌 및 이의치료 용도 |
| NL1018991C2 (nl) * | 2001-09-20 | 2003-03-21 | Tno | Vochtwerende eetbare bekledingslaag voor voedingsmiddelen. |
| US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
| KR100491647B1 (ko) * | 2002-11-21 | 2005-05-27 | 한국화학연구원 | 알긴산 나트륨 피복층을 포함하는 벤즈 이미다졸 유도체의경구체제 및 그의 제조방법 |
| US7122370B2 (en) * | 2003-01-14 | 2006-10-17 | Randolph Stanley Porubcan | Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life |
| DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
| DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
| GB0320522D0 (en) * | 2003-09-02 | 2003-10-01 | Glaxo Group Ltd | Formulation |
| DK1514553T3 (da) * | 2003-09-05 | 2008-06-23 | Myung-Jun Chung | Mælkesyrebakteriepulver, der er dobbeltbelagt under anvendelse af protein og polysaccharid og fremgangsmåde til fremstilling af samme samt dosisform af dette |
| DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| WO2006012536A2 (en) | 2004-07-22 | 2006-02-02 | Ritter Andrew J | Methods and compositions for treating lactose intolerance |
| DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| JP5576606B2 (ja) | 2005-05-18 | 2014-08-20 | ディーエスエム アイピー アセッツ ビー.ブイ. | 微生物の腸内投与用組成物 |
| US8343547B2 (en) | 2006-08-08 | 2013-01-01 | Shin-Etsu Chemical Co., Ltd. | Solid dosage form comprising solid dispersion |
| US8343548B2 (en) * | 2006-08-08 | 2013-01-01 | Shin-Etsu Chemical Co., Ltd. | Solid dosage form comprising solid dispersion |
| US8519120B2 (en) | 2006-08-08 | 2013-08-27 | Shin-Etsu Chemical Co., Ltd. | Methods for producing a low-substituted hydroxypropylcellulose powder |
| CN102159225B (zh) * | 2008-09-17 | 2013-11-13 | 亨特免疫有限公司 | 不可分型流感嗜血杆菌疫苗和它们的用途 |
| EP2400839B1 (de) | 2009-02-24 | 2016-09-07 | Ritter Pharmaceuticals, Inc. | Präbiotische formulierungen und verwendungsverfahren dafür |
| CN102639118B (zh) | 2009-07-22 | 2015-07-29 | 格吕伦塔尔有限公司 | 氧化稳定的抗干扰剂型 |
| KR101738369B1 (ko) | 2009-07-22 | 2017-05-22 | 그뤼넨탈 게엠베하 | 핫 멜트 압출된 제어 방출 투여형 |
| EP3202406A1 (de) | 2010-04-28 | 2017-08-09 | Ritter Pharmaceuticals, Inc. | Präbiotische formulierungen und deren verwendungen |
| US8940858B2 (en) * | 2010-05-17 | 2015-01-27 | Northwestern University | Fibrous microcapsules and methods of assembly and use thereof |
| BR112013005194A2 (pt) | 2010-09-02 | 2016-05-03 | Gruenenthal Gmbh | forma de dosagem resistente à violação compreendendo sal inorgânico |
| BR112014001091A2 (pt) | 2011-07-29 | 2017-02-14 | Gruenenthal Gmbh | comprimido resistente à adulteração que fornece liberação imediata do fármaco |
| EA201400172A1 (ru) | 2011-07-29 | 2014-06-30 | Грюненталь Гмбх | Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства |
| EP2838512B1 (de) | 2012-04-18 | 2018-08-22 | Grünenthal GmbH | Fälschungssichere und dose dumping sichere pharmazeutische darreichungsform |
| US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
| EP3003279A1 (de) | 2013-05-29 | 2016-04-13 | Grünenthal GmbH | Manipulationssichere darreichungsform mit einem oder mehreren partikeln |
| BR112016000194A8 (pt) | 2013-07-12 | 2019-12-31 | Gruenenthal Gmbh | forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila |
| EP3073994A1 (de) | 2013-11-26 | 2016-10-05 | Grünenthal GmbH | Herstellung einer pulverförmigen pharmazeutischen zusammensetzung mittels kryogenen mahlens |
| EP3125905A4 (de) | 2014-04-04 | 2017-11-08 | Ritter Pharmaceuticals, Inc. | Verfahren und zusammensetzungen für mikrobiomveränderung |
| WO2015173195A1 (en) | 2014-05-12 | 2015-11-19 | Grünenthal GmbH | Tamper resistant immediate release capsule formulation comprising tapentadol |
| KR102392313B1 (ko) * | 2014-09-03 | 2022-05-02 | 라이온 가부시키가이샤 | 코팅 제제 및 그 제조 방법 |
| US11865099B2 (en) | 2015-07-17 | 2024-01-09 | Laboratori Baldacci S.P.A. | Product based on iron bis-glycinate chelate and alginic acid and/or water-soluble salts thereof, formulations thereof, and pharmaceutical uses thereof |
| ITUB20152290A1 (it) * | 2015-07-17 | 2017-01-17 | Laboratori Baldacci Spa | Prodotto a base di ferro bisglicinato chelato e acido alginico e/o suoi sali idrosolubili, sue formulazioni ed suoi usi farmaceutici |
| JP2018526414A (ja) | 2015-09-10 | 2018-09-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護 |
| CN115252650A (zh) | 2015-11-03 | 2022-11-01 | 布里格姆及妇女医院股份有限公司 | 用于治疗和/或预防食物变态反应的治疗性微生物群 |
| US20170296476A1 (en) * | 2016-04-15 | 2017-10-19 | Grünenthal GmbH | Modified release abuse deterrent dosage forms |
| US10618042B1 (en) | 2017-05-31 | 2020-04-14 | University Of South Florida | Mixed metal oxide extrudate catalyst |
| WO2019118984A2 (en) | 2017-12-15 | 2019-06-20 | Solarea Bio, Inc. | Microbial compositions and methods for treating type 2 diabetes, obesity, and metabolic syndrome |
| FR3083545A1 (fr) | 2018-07-04 | 2020-01-10 | Institut National De La Recherche Agronomique | Utilisation d'une souche de roseburia intestinalis pour la prevention et le traitement de l'inflammation de l'intestin |
| US11980647B2 (en) | 2018-09-05 | 2024-05-14 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause |
| CA3111795A1 (en) | 2018-09-05 | 2020-03-12 | Solarea Bio, Inc. | Methods and compositions for treating musculoskeletal diseases |
| EP3646857A1 (de) | 2018-11-01 | 2020-05-06 | Evonik Operations GmbH | System zur abgabe von mikroorganismen im dickdarm |
| CA3116415A1 (en) | 2018-11-05 | 2020-05-14 | MarvelBiome, Inc. | Microbial compositions comprising ellagitannin and methods of use |
| EP3986163A2 (de) | 2019-06-19 | 2022-04-27 | Solarea Bio, Inc. | Mikrobielle zusammensetzungen und verfahren zur herstellung von aufgewerteten probiotischen zusammenstellungen |
| US20240252442A1 (en) * | 2021-07-29 | 2024-08-01 | Nutrition & Biosciences Usa 1, Llc | Controlled release coating agent |
| CA3238788A1 (en) | 2021-11-22 | 2023-05-25 | Eric Michael Schott | Methods and compositions for treating musculoskeletal diseases, treating inflammation, and managing symptoms of menopause |
| US20230190834A1 (en) | 2021-12-21 | 2023-06-22 | Solarea Bio, Inc. | Immunomodulatory compositions comprising microbial entities |
| WO2025064621A1 (en) | 2023-09-19 | 2025-03-27 | Flagship Pioneering Innovations Vi, Llc | Compositions and methods for treating colorectal cancer |
| WO2025064645A1 (en) | 2023-09-19 | 2025-03-27 | Flagship Pioneering Innovations Vi, Llc | Compositions and methods for treating inflammatory bowel disease |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE338976B (de) * | 1970-01-29 | 1971-09-27 | Foerenade Superfosfatfab Ab | |
| GB1509866A (en) * | 1975-06-10 | 1978-05-04 | Johnson & Johnson | Enteric coated digestive enzyme compositions |
| JPS59193831A (ja) | 1983-04-18 | 1984-11-02 | Sankyo Co Ltd | 腸溶性製剤の製造法 |
| CN1034489A (zh) * | 1987-12-11 | 1989-08-09 | 福建省水产研究所 | 一种制作肠溶胶囊的方法 |
| CN1033441A (zh) * | 1987-12-11 | 1989-06-21 | 福建省水产研究所 | 用褐藻胶制肠溶片剂的方法 |
| US5733575A (en) * | 1994-10-07 | 1998-03-31 | Bpsi Holdings, Inc. | Enteric film coating compositions, method of coating therewith, and coated forms |
| US5674495A (en) * | 1995-02-27 | 1997-10-07 | Purdue Research Foundation | Alginate-based vaccine compositions |
| WO1997000674A1 (en) * | 1995-06-20 | 1997-01-09 | Pharma-Vinci A/S | A method of preparing an oral preparation provided on the outer side with an enteric coating, as well as an oral preparation obtained by the method |
-
1997
- 1997-06-06 AU AU30263/97A patent/AU717817B2/en not_active Expired
- 1997-06-06 DE DE69730991T patent/DE69730991T2/de not_active Expired - Lifetime
- 1997-06-06 IL IL12737897A patent/IL127378A/xx not_active IP Right Cessation
- 1997-06-06 CN CNB971959986A patent/CN1147291C/zh not_active Expired - Lifetime
- 1997-06-06 AT AT97924938T patent/ATE277605T1/de not_active IP Right Cessation
- 1997-06-06 BR BR9709535-4A patent/BR9709535A/pt not_active IP Right Cessation
- 1997-06-06 JP JP10500114A patent/JP2000514406A/ja active Pending
- 1997-06-06 CA CA002257378A patent/CA2257378C/en not_active Expired - Lifetime
- 1997-06-06 KR KR1019980709904A patent/KR20000016331A/ko not_active Withdrawn
- 1997-06-06 WO PCT/DK1997/000252 patent/WO1997046224A1/en not_active Ceased
- 1997-06-06 EP EP97924938A patent/EP0952824B1/de not_active Expired - Lifetime
- 1997-06-06 US US09/194,922 patent/US6455052B1/en not_active Expired - Lifetime
- 1997-06-06 NZ NZ333182A patent/NZ333182A/xx not_active IP Right Cessation
-
1998
- 1998-12-04 NO NO19985699A patent/NO327294B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US6455052B1 (en) | 2002-09-24 |
| NO327294B1 (no) | 2009-06-02 |
| WO1997046224A1 (en) | 1997-12-11 |
| NZ333182A (en) | 2000-03-27 |
| DE69730991D1 (de) | 2004-11-04 |
| AU3026397A (en) | 1998-01-05 |
| EP0952824A1 (de) | 1999-11-03 |
| IL127378A (en) | 2003-07-31 |
| KR20000016331A (ko) | 2000-03-25 |
| CA2257378C (en) | 2009-04-07 |
| CN1223573A (zh) | 1999-07-21 |
| CA2257378A1 (en) | 1997-12-11 |
| NO985699D0 (no) | 1998-12-04 |
| JP2000514406A (ja) | 2000-10-31 |
| IL127378A0 (en) | 1999-10-28 |
| AU717817B2 (en) | 2000-04-06 |
| DE69730991T2 (de) | 2006-02-23 |
| NO985699L (no) | 1999-02-08 |
| EP0952824B1 (de) | 2004-09-29 |
| BR9709535A (pt) | 2000-01-11 |
| CN1147291C (zh) | 2004-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE277605T1 (de) | Alginsaure enthaltende enterischer ueberzug fuer eine orale zubereitung | |
| GB2186485B (en) | Slow release formulation | |
| CA2303852A1 (en) | Fish gelatin compositions containing a hydrocolloid setting system | |
| DK0569468T3 (da) | Anvendelse af et enzymholdigt granulat og en fremgangsmåde til fremstilling af et tabletteret foderstof | |
| RU94016167A (ru) | Фармацевтическая композиция, способы доставки биологически активного вещества, способы лечения, способы стимулирования | |
| PL330178A1 (en) | Precipitated silicic acids containing active substance, method of obtaining them and mouth care agent based on such acids | |
| AU5099400A (en) | Microencapsulated and controlled-release herbal formulations | |
| ATE297223T1 (de) | Teilchenförmige vitaminzubereitung | |
| DE69919003D1 (de) | Acetaminophen-formulierung mit verlängerter freisetzung | |
| CA2339931A1 (en) | Extended release acetaminophen | |
| TR199802670T2 (xx) | Pestisidal tablet form�lasyonlar�. | |
| DE69101490D1 (de) | Verfahren zum Einbauen in Pellets von gegen Abbau im Pansen von Wiederkäuern geschützten Wirkstoffen. | |
| EP0968713A4 (de) | Isosorbidnitrat enthaltentende pflaster | |
| DE69813846T2 (de) | Geschmacksmaskierung schlecht schmeckender formulierungen | |
| ES2164566A1 (es) | Preparacion cosmetica o dermofarmaceutica compuesta de milicapsulas conrecubrimiento de polisacaridos cationicos. | |
| TW246642B (en) | Pharmaceutical or vaccinal microcapsule capable of inhibiting activity-reduction caused by gastric acid and protein decomposition enzyme | |
| JPS5573608A (en) | Stable diagnosing drug for radioactive technetium labeling | |
| ZA852923B (en) | N-(3-phenylmethylthio-1-oxoporpyl)aminoacetic acid derivatives,their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |